Doses | Patient category | Control n (%) | Intervention n (%) | All patients n (%) | OR (95% CI) | p value |
---|---|---|---|---|---|---|
Dose 2 | 1 | N = 237 | N = 241 | n = 478 |  |  |
 Adherent |  | 192 (81.0) | 186 (77.2) | 378 (79.1) | 0.76 (0.48–1.19) | 0.233 |
Dose 3 | 1 | Â | Â | Â | Â | Â |
 Adherent |  | 230 (97.1) | 235 (97.5) | 465 (97.3) | 1.19 (0.39–3.59) | 0.762 |
Dose 4 | 2 | NÂ =Â 226 | NÂ =Â 239 | NÂ =Â 465 | Â | Â |
 Adherent |  | 205 (90.7) | 223 (93.3) | 428 (92.0) | 1.43 (0.73–2.81) | 0.303 |
Dose 5 | 2 | Â | Â | Â | Â | Â |
 Adherent |  | 207 (91.6) | 220 (92.1) | 427 (91.8) | 1.06 (0.55–2.06) | 0.857 |
Dose 6 | 3 | NÂ =Â 289 | NÂ =Â 273 | NÂ =Â 562 | Â | Â |
 Adherent |  | 256 (88.6) | 249 (91.2) | 505 (89.9) | 1.30 (0.74–2.28) | 0.355 |